464 related articles for article (PubMed ID: 37561647)
1. Complex Coacervates as a Promising Vehicle for mRNA Delivery: A Comprehensive Review of Recent Advances and Challenges.
Forenzo C; Larsen J
Mol Pharm; 2023 Sep; 20(9):4387-4403. PubMed ID: 37561647
[TBL] [Abstract][Full Text] [Related]
2. Recent Advances in Complex Coacervation Design from Macromolecular Assemblies and Emerging Applications.
Zhou L; Shi H; Li Z; He C
Macromol Rapid Commun; 2020 Nov; 41(21):e2000149. PubMed ID: 32431012
[TBL] [Abstract][Full Text] [Related]
3. Phase-separating peptides for direct cytosolic delivery and redox-activated release of macromolecular therapeutics.
Sun Y; Lau SY; Lim ZW; Chang SC; Ghadessy F; Partridge A; Miserez A
Nat Chem; 2022 Mar; 14(3):274-283. PubMed ID: 35115657
[TBL] [Abstract][Full Text] [Related]
4. mRNA therapeutics for disease therapy: principles, delivery, and clinical translation.
Zhou DW; Wang K; Zhang YA; Ma K; Yang XC; Li ZY; Yu SS; Chen KZ; Qiao SL
J Mater Chem B; 2023 Apr; 11(16):3484-3510. PubMed ID: 36988384
[TBL] [Abstract][Full Text] [Related]
5. Insight into RNA-based Therapies for Ovarian Cancer.
Keyvani V; Mahmoudian RA; Mollazadeh S; Kheradmand N; Ghorbani E; Khazaei M; Saeed Al-Hayawi I; Hassanian SM; Ferns GA; Avan A; Anvari K
Curr Pharm Des; 2023; 29(34):2692-2701. PubMed ID: 37916491
[TBL] [Abstract][Full Text] [Related]
6. Coacervates: Recent developments as nanostructure delivery platforms for therapeutic biomolecules.
Ban E; Kim A
Int J Pharm; 2022 Aug; 624():122058. PubMed ID: 35905931
[TBL] [Abstract][Full Text] [Related]
7. RNAi therapies: Expanding applications for extrahepatic diseases and overcoming delivery challenges.
Won Lee J; Kyu Shim M; Kim H; Jang H; Lee Y; Hwa Kim S
Adv Drug Deliv Rev; 2023 Oct; 201():115073. PubMed ID: 37657644
[TBL] [Abstract][Full Text] [Related]
8. Degradation and hemostatic properties of polyphosphate coacervates.
Momeni A; Filiaggi MJ
Acta Biomater; 2016 Sep; 41():328-41. PubMed ID: 27265150
[TBL] [Abstract][Full Text] [Related]
9. Synthetic modified messenger RNA for therapeutic applications.
Gao M; Zhang Q; Feng XH; Liu J
Acta Biomater; 2021 Sep; 131():1-15. PubMed ID: 34133982
[TBL] [Abstract][Full Text] [Related]
10. Nanotechnology-Assisted RNA Delivery: From Nucleic Acid Therapeutics to COVID-19 Vaccines.
Rinoldi C; Zargarian SS; Nakielski P; Li X; Liguori A; Petronella F; Presutti D; Wang Q; Costantini M; De Sio L; Gualandi C; Ding B; Pierini F
Small Methods; 2021 Sep; 5(9):e2100402. PubMed ID: 34514087
[TBL] [Abstract][Full Text] [Related]
11. Peptide-based coacervates in therapeutic applications.
Ma L; Fang X; Wang C
Front Bioeng Biotechnol; 2022; 10():1100365. PubMed ID: 36686257
[TBL] [Abstract][Full Text] [Related]
12. Redox-responsive peptide-based complex coacervates as delivery vehicles with controlled release of proteinous drugs.
Wang J; Abbas M; Huang Y; Wang J; Li Y
Commun Chem; 2023 Nov; 6(1):243. PubMed ID: 37935871
[TBL] [Abstract][Full Text] [Related]
13. Developing Biodegradable Lipid Nanoparticles for Intracellular mRNA Delivery and Genome Editing.
Qiu M; Li Y; Bloomer H; Xu Q
Acc Chem Res; 2021 Nov; 54(21):4001-4011. PubMed ID: 34668716
[TBL] [Abstract][Full Text] [Related]
14. mRNA-based therapeutics: powerful and versatile tools to combat diseases.
Qin S; Tang X; Chen Y; Chen K; Fan N; Xiao W; Zheng Q; Li G; Teng Y; Wu M; Song X
Signal Transduct Target Ther; 2022 May; 7(1):166. PubMed ID: 35597779
[TBL] [Abstract][Full Text] [Related]
15. Coacervate delivery systems for proteins and small molecule drugs.
Johnson NR; Wang Y
Expert Opin Drug Deliv; 2014 Dec; 11(12):1829-32. PubMed ID: 25138695
[TBL] [Abstract][Full Text] [Related]
16. Understanding the Impacts of Molecular and Macromolecular Crowding Agents on Protein-Polymer Complex Coacervates.
Biswas S; Hecht AL; Noble SA; Huang Q; Gillilan RE; Xu AY
Biomacromolecules; 2023 Nov; 24(11):4771-4782. PubMed ID: 37815312
[TBL] [Abstract][Full Text] [Related]
17. Accelerating Payload Release from Complex Coacervates through Mechanical Stimulation.
Hatem WA; Lapitsky Y
Polymers (Basel); 2023 Jan; 15(3):. PubMed ID: 36771888
[TBL] [Abstract][Full Text] [Related]
18. Self-coacervation of carboxymethyl chitosan as a pH-responsive encapsulation and delivery strategy.
Jing H; Du X; Mo L; Wang H
Int J Biol Macromol; 2021 Dec; 192():1169-1177. PubMed ID: 34678379
[TBL] [Abstract][Full Text] [Related]
19. Delivery of synthetic mRNAs for tissue regeneration.
Steinle H; Weber J; Stoppelkamp S; Große-Berkenbusch K; Golombek S; Weber M; Canak-Ipek T; Trenz SM; Schlensak C; Avci-Adali M
Adv Drug Deliv Rev; 2021 Dec; 179():114007. PubMed ID: 34710530
[TBL] [Abstract][Full Text] [Related]
20. Advances in mRNA non-viral delivery approaches.
Ibba ML; Ciccone G; Esposito CL; Catuogno S; Giangrande PH
Adv Drug Deliv Rev; 2021 Oct; 177():113930. PubMed ID: 34403751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
